The Japanese unit of Swiss pharmaceutical giant Novartis has been ordered to temporarily suspend its operations for failing to report drug side effects, revealed the health ministry. This is reportedly a first for a pharmaceutical firm operating in Japan. During the 15-day suspension, which is to start from March 5, the company will not be able to sell most of its drugs. Drug-makers are required to report serious side effects of any drugs to the ministry within ...Sunday, 1 March 2015
Novartis Japan Hit With 15-day Suspension for Failing to Report Drug Side Effects
The Japanese unit of Swiss pharmaceutical giant Novartis has been ordered to temporarily suspend its operations for failing to report drug side effects, revealed the health ministry. This is reportedly a first for a pharmaceutical firm operating in Japan. During the 15-day suspension, which is to start from March 5, the company will not be able to sell most of its drugs. Drug-makers are required to report serious side effects of any drugs to the ministry within ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment